DONALD BLACKBURN: Open Payments
NPI 1174294227 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,263 in 67 payments from 15 companies in 2025. Trend: 2023 $2,701 · 2024 $2,272 · 2025 $1,263
Food & beverage: $1,263
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $220 |
| Otsuka America Pharmaceutical, Inc. | 7 | $159 |
| Alkermes, Inc. | 16 | $152 |
| Janssen Pharmaceuticals, Inc | 5 | $117 |
| Neuronetics, Inc. | 1 | $101 |
| Vanda Pharmaceuticals Inc. | 5 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $87 |
| Lundbeck LLC | 4 | $73 |
| Noven Therapeutics, LLC | 3 | $62 |
| Axsome Therapeutics, Inc. | 3 | $58 |
Products named: VRAYLAR, REXULTI, LYBALVI, NEUROSTAR TMS THERAPY SYSTEM, CAPLYTA, ABILIFY MAINTENA, Xelstrym, INVEGA SUSTENNA.
Industry payments across KY — which companies pay providers there.
